Canadian Active Drug Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Psoriasis

Brief summary

This was a Canadian post-marketing observational study (PMOS) utilizing a prospective cohort design that compared the real - life effectiveness of an active drug to topical and traditional systemic agents in the management of psoriasis and its impact on the patient's quality of life and societal burden of illness.

Observational study

662 patients
Protocol ID:
Observational model:
Time perspective:


Eligibility criteria

Participant attributes:
Male and Female


18 Years and older.

Inclusion Criteria:

- Active moderate or severe plaque psoriasis according to the judgment of the treating

- The treating physician has decided to change the current treatment or add additional
treatments for any reason including but not limited to inadequate response,
intolerance, sub-optimal compliance or participant preference.

Exclusion Criteria:

- Had currently participated in another prospective study with similar objectives.

- Participant could not or would not sign informed consent.

- Presence of other condition that, in the opinion of the treating physician, prohibits
the participant from participating in the study or obscured the assessment of the
treatment of plaque psoriasis.

All the cities where the clinical studies are located

Calgary - T2G 1B1
Calgary - T2T 5C7
Calgary - T3A 2N1
Edmonton - T5N 4B2
Edmonton - T6G 1C3
Nanaimo - V9T 1W1
Victoria - V8V 3M9
St. John's - A1A 4Y3
St. John's - A1B 5E8
Halifax - B3H 0A2
Barrie - L4M 7G1
Etobicoke - M8X 1Y9
Hamilton - L8N 1Y2
London - N6H 5L5
Markham - L3P 1X2
Mississauga - L4Y 1A6
Mississauga - L5M 2V8
Oakville - L6J 7W5
Peterborough - K9J 5K2
Richmond Hill - L4C 9M7
St-catharines - L2R 5W4
Sudbury - P3C 1X8
Thornhill - L4J 3M6
Toronto - M3H 5Y8
Drummondville - J2B 5L4
Montreal - J7Z 3B8
Pierrefonds - H8Z 1W5
Verdun - H4G 3E7
Westmount - H3Z 2S6
Saskatoon - S7N 0W8
Bathurst - E2A 4X7
Fredericton - E3B 1G9
Moncton - E1C 8X3
Quispamsis - E2E 4Z4
Brandon - R7A 0L5
Winnipeg - R3C 1T6

More information about this study